Home  ›  Science Center  ›  EquiNectar Leisure Horse Microbiome & Metabolome Study
Peer reviewed EQN-S04

EquiNectar Leisure Horse Microbiome & Metabolome Study

Peer-reviewed research in 10 leisure horses found measurable changes in both the fecal metabolome and microbiome after eight weeks of EquiNectar supplementation, including higher mean short-chain fatty acids and shifts in several fibre-associated bacterial groups.

Original study title

Innovative Approaches to Managing the Mammalian Microbiome: Evidence for the Role of Anabiomics

Microbiome Metabolome Short-chain fatty acids Volatile organic compounds Leisure horses
Study at a glance
Year 2026
Study type Prospective before-and-after intervention study
Sample 10 horses; 8 paired sample sets used for 16S microbiome analysis
Duration 8 weeks
Population Non-Thoroughbred leisure horses
Publication Peer-reviewed journal article
EquiNectar tested? Yes
Peer reviewed Yes
Open access Yes
Relationship
1,376 → 2,077 ppb
Total mean fecal short-chain fatty acids
505 → 737 ppb
Mean fecal acetic acid
533 → 938 ppb
Mean fecal propionic acid
335 → 405 ppb
Mean fecal butyric acid
Research question

What did the researchers want to understand?

Does eight weeks of EquiNectar supplementation produce measurable changes in the fecal metabolome and gut microbiome of leisure horses maintained on their normal diets?

Researchers

Study authors

Rosemary Waring


University of Birmingham
Tharos Ltd

T. Forcht Dagi

PhD
Professor

Mayo Alix College of Medicine and Science

John O. Hunter


Professor

Tharos Ltd
Addenbrooke's Hospital
Research organizations

Research institutions

University of Birmingham

University

Mayo Alix College of Medicine and Science

Medical school / research institution
United States

Addenbrooke's Hospital

Hospital
United Kingdom
Methodology

How the study was conducted

Study design

Ten non-Thoroughbred leisure horses kept at a stable yard near Cambridge, Cambridgeshire, UK were maintained on their standard diets.

Baseline fecal samples were collected and frozen at −80°C.

The horses then received EquiNectar at 150 ml twice daily, approximately 0.7 ml/kg body weight, alongside their normal diet for eight weeks.

At the end of the supplementation period, fecal samples were collected again and analyzed using SIFT-MS metabolomics and 16S microbiome analysis.

The study used a before-and-after design and did not include a separate untreated control group.

What was measured

Fecal samples were collected before supplementation and again after eight weeks.

The fecal metabolome was analyzed using specific ion flow tube mass spectrometry (SIFT-MS). Five grams of each fecal sample were incubated under standardized conditions before volatile compounds in the sample headspace were measured.

The resulting metabolomic data were analyzed using principal component analysis and machine-learning approaches including partial least squares discriminant analysis, random forest and Bayesian additive regression trees.

The researchers measured volatile metabolites including acetic, propionic and butyric acids, ammonia, methanol, ethanol, acetone and dimethyl disulphide.

For microbiome analysis, eight paired fecal sample sets underwent DNA isolation and 16S rRNA analysis using the Illumina platform. This allowed bacterial populations to be examined from phylum through to species level.

Study findings

Key results

• Mean total fecal short-chain fatty acids increased from 1,376 ppb before supplementation to 2,077 ppb after eight weeks.

• Mean acetic acid increased from 505 to 737 ppb.

• Mean propionic acid increased from 533 to 938 ppb.

• Mean butyric acid increased from 335 to 405 ppb.

• Mean ethanol decreased from 1,998 to 1,252 ppb, while mean dimethyl disulphide decreased from 53 to 33 ppb.

• Post-supplementation microbiome profiles tended to converge compared with the greater individual variation seen at baseline.

• Reported microbiome changes included generally lower Spirochaetes alongside increases in bacterial groups including Fibrobacter, Ruminococcaceae, Blautia and Oscillospira.

• Increased species richness was also reported after supplementation.

Interpretation

What do the findings mean?

The study found concurrent changes in the fecal metabolome and microbiome following eight weeks of EquiNectar supplementation.

Mean total short-chain fatty acids increased from 1,376 ppb before supplementation to 2,077 ppb afterwards. Mean acetic, propionic and butyric acid concentrations all increased, while mean ethanol and dimethyl disulphide concentrations decreased.

Microbiome analysis showed that individual horses differed substantially at baseline, but post-supplementation profiles tended to become more similar. Reported changes included lower Spirochaetes and increases in Fibrobacter, Ruminococcaceae, Blautia, Oscillospira and Paraprevotella across individual horses.

Together, these findings show a measurable change in both microbial composition and microbial metabolic output during EquiNectar supplementation.

Because the study lacked an untreated control group, the findings demonstrate an association with the eight-week intervention rather than proving that every observed change was caused solely by EquiNectar.

In practice

Why this research matters

The equine hindgut microbiome converts dietary material into metabolites including short-chain fatty acids, which contribute substantially to energy supply in the horse.

In this study, mean fecal concentrations of acetic, propionic and butyric acid were all higher after eight weeks of EquiNectar supplementation. At the same time, microbiome analysis identified changes in bacterial groups associated with fibre degradation and short-chain fatty-acid production.

This is important because it demonstrates changes at two different levels: the organisms present in the microbial community and the metabolic products being produced by that community.

The findings support the concept that changing digestion upstream can influence the downstream hindgut environment. However, fecal measurements remain indirect measures of conditions within the cecum and colon.

Research transparency

Study limitations

This was a small before-and-after study involving 10 non-Thoroughbred leisure horses and did not include a separate untreated control group.

The horses remained on their standard diets, but without a contemporaneous control group it is not possible to exclude all effects of time, environment or other unmeasured factors.

Metabolomic measurements were available for the 10-horse cohort, while 16S microbiome analysis was conducted on eight paired fecal sample sets.

The study used fecal samples as a practical proxy for the intestinal environment. Fecal microbiome and metabolome measurements do not directly measure conditions within the cecum or colon.

The paper reports substantial changes in mean metabolite concentrations and overall metabolomic profiles, but does not provide confidence intervals or individual statistical tests for each short-chain fatty acid reported in Table 1.

No clinical outcomes such as performance, body condition, fecal consistency or incidence of gastrointestinal disease were systematically assessed, so the study should not be interpreted as demonstrating treatment of a specific clinical condition.

EquiNectar context

How this research relates to EquiNectar

This study directly evaluated EquiNectar in non-Thoroughbred leisure horses.

The horses received 150 ml of EquiNectar twice daily for eight weeks while remaining on their standard diets. Fecal samples collected before and after supplementation were analyzed using both metabolomics and 16S microbiome analysis.

The study therefore provides direct peer-reviewed evidence that EquiNectar supplementation was associated with measurable changes in both microbial metabolic activity and bacterial community composition.

Tharos / EquiNectar involvement

This study directly evaluated EquiNectar, described in the published paper as Enzyme Rich Malt Extract (ERME). The methods identify ERME with Tharos Ltd, London, UK. The acknowledgements state that ERME is a registered trademark of Ateria Health Ltd and was provided for the studies by the company. The paper does not provide a separate funding statement and the authors declared no conflict of interest.

EquiNectar evaluated Yes
Source record

Publication details

Publisher
Innovation Forever Publishing Group Limited
Year
2026
Volume
3
Pages / article
10
Species
Horse
Population
Non-Thoroughbred leisure horses
Sample
10 horses; 8 paired sample sets used for 16S microbiome analysis
Duration
8 weeks
License
CC BY 4.0
Recommended citation

Waring RH, Dagi TF, Hunter JO. Innovative Approaches to Managing the Mammalian Microbiome: Evidence for the Role of Anabiomics. Journal of Modern Agriculture and Biotechnology. 2024;3:10. doi:10.53964/jmab.2024010.